《LANCET,4月2日,Monitoring behavioural insights related to COVID-19》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-04-03
  • Monitoring behavioural insights related to COVID-19

    Cornelia Betsch

    Lothar H Wieler

    Katrine Habersaat

    on behalf of theCOSMO group†

    Show footnotes

    Published:April 02, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30729-7

    The rapidly evolving coronavirus disease 2019 (COVID-19) pandemic is placing an overwhelming burden on health systems and authorities to respond with effective and appropriate interventions, policies, and messages. A critical element in reducing transmission of the virus is rapid and widespread behavioural change. Evidence shows that a perceived lack of consistency, competence, fairness, objectivity, empathy, or sincerity in crisis response in the public could lead to distrust and fear.1 Conversely, when the public perceives measures as having these characteristics, as well as being easily understood and communicated through trusted and accessible channels, and when the necessary services are available, people are able to make informed choices, protect themselves, and comply with recommended practices.

  • 原文来源:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30729-7/fulltext
相关报告
  • 《LANCET,4月2日,Monitoring the COVID-19 epidemic in the context of widespread local transmission》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-05
    • Monitoring the COVID-19 epidemic in the context of widespread local transmission Alberto L García-Basteiro Carlos Chaccour Caterina Guinovart Anna Llupià Joe Brew Antoni Trilla et al. Published:April 02, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30162-4 Coronavirus disease 2019 (COVID-19) is a novel viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first detected in Wuhan, China, in December, 2019.1 Given the fast spread, the severity of disease, the increasing number of cases outside China, and the number of affected countries, WHO declared the rapid spread of SARS-CoV-2 a pandemic on March 11, 2020.2 The availability of reliable surveillance platforms is crucial to monitor the COVID-19 epidemic in a timely manner and to respond with adequate control measures. Since the beginning of the outbreak, different countries have used different testing approaches and criteria, depending on their resources and capacity.
  • 《Nature,4月20日,The need for urogenital tract monitoring in COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-21
    • The need for urogenital tract monitoring in COVID-19 Shangqian Wang, Xiang Zhou, Tongtong Zhang & Zengjun Wang Nature Reviews Urology (2020) Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-19 infection also has implications for the urogenital tract. Thus, urogenital organs should be considered when treating COVID-19.